Palisade Bio (PALI)
(Delayed Data from NSDQ)
$0.88 USD
-0.12 (-12.16%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.79 -0.09 (-10.06%) 5:38 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Palisade Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PALI 0.88 -0.12(-12.16%)
Will PALI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PALI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PALI
Palisade Bio (PALI) Upgraded to Buy: What Does It Mean for the Stock?
PALI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PALI
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel ...
Palisade Bio announces new data from ongoing program evaluating PALI-2108
Palisade Bio (PALI) Secures Key Patent Approval in China
Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead ...
Palisade Bio receives notice of allowance for patent of PALI-2108 in China